Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation

Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation

Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are related strains capable of inducing severe gastrointestinal disease. For optimal infection, these pathogens actively modulate cellular functions through the deployment of effector proteins in a type three secretion system (T...

Full description

Bibliographic Details
Main Authors:	Yen, Hilo, Sugimoto, Nakaba, Tobe, Toru
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557958/

Similar Items

Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli
by: Yen, Hilo, et al.
Published: (2016)

The enteropathogenic Escherichia coli effector NleH inhibits apoptosis induced by Clostridium difficile toxin B
by: Robinson, Keith S., et al.
Published: (2010)

A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation
by: Pearson, Jaclyn S, et al.
Published: (2011)

Expression and Regulation of the Escherichia coli O157:H7 Effector Proteins NleH1 and NleH2
by: Holmes, Ashleigh, et al.
Published: (2012)

Emerging Enteropathogenic Escherichia coli Strains?
by: Gomes, Tânia A.T., et al.
Published: (2004)

Antisense Transcription Regulates the Expression of the Enterohemorrhagic Escherichia coli Virulence Regulatory Gene ler in Response to the Intracellular Iron Concentration
by: Tobe, Toru, et al.
Published: (2014)

The role of the NLRP3 inflammasome in gout
by: Kingsbury, Sarah R, et al.
Published: (2011)

The Role of the NLRP3 Inflammasome in Fibrosis
by: Artlett, Carol M
Published: (2012)

NLRP3 Inflammasome and MS/EAE
by: Inoue, Makoto, et al.
Published: (2013)

NLRP3 Inflammasome and Pathobiology in AMD
by: Celkova, Lucia, et al.
Published: (2015)

Lactobacillus reuteri Inhibition of Enteropathogenic Escherichia coli Adherence to Human Intestinal Epithelium
by: Walsham, Alistair D. S., et al.
Published: (2016)

Atypical Enteropathogenic Escherichia coli: Typical Pathogens?
by: Nataro, James P.
Published: (2006)

relA Enhances the Adherence of Enteropathogenic Escherichia coli
by: Spira, Beny, et al.
Published: (2014)

Quantification of enteropathogenic Escherichia coli from retailed meats
by: Nor Fathihah binti Mamat
Published: (2014)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
by: Saresella, Marina, et al.
Published: (2016)

Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
by: Du, Ren-Hong, et al.
Published: (2016)

Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia
by: Cai, Yang, et al.
Published: (2016)

NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
by: Tavares, Aldo Henrique, et al.
Published: (2013)

NLRP3 Inflammasome Activation by Viroporins of Animal Viruses
by: Guo, Hui-Chen, et al.
Published: (2015)

Vimentin regulates activation of the NLRP3 inflammasome
by: dos Santos, Gimena, et al.
Published: (2015)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
by: Paramel Varghese, Geena, et al.
Published: (2016)

Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome
by: Cheong, Woo-Chang, et al.
Published: (2015)

Role of the Nlrp3 Inflammasome in Microbial Infection
by: Anand, Paras K., et al.
Published: (2011)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
by: Bo-Zong Shao, et al.
Published: (2018-09-01)

Cytochrome c Negatively Regulates NLRP3 Inflammasomes
by: Shi, Chong-Shan, et al.
Published: (2016)

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
by: Wan, Xingyong, et al.
Published: (2016)

NLRP3 inflammasome and its inhibitors: a review
by: Shao, Bo-Zong, et al.
Published: (2015)

Fatty acid synthesis and NLRP3-inflammasome
by: Moon, Jong-Seok, et al.
Published: (2015)

Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
by: Nuvolone, Mario, et al.
Published: (2015)

Dynamics of the Type III Secretion System Activity of Enteropathogenic Escherichia coli
by: Mills, Erez, et al.
Published: (2013)

The E. coli Effector Protein NleF Is a Caspase Inhibitor
by: Blasche, Sonja, et al.
Published: (2013)

The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
by: Song, Hui, et al.
Published: (2016)

Molecular Characterization of Clinical Isolates of Enteropathogenic Escherichia Coli from Miri Sarawak
by: Lah, Irene
Published: (2004)

Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivity
by: Zahavi, Eitan E., et al.
Published: (2011)

Distinct Interaction of Two Atypical Enteropathogenic Escherichia coli Strains with Enterocytes In Vitro
by: Sampaio, Suely C. F, et al.
Published: (2011)

Enteropathogenic Escherichia coli Associated with Diarrhea in Children in Cairo, Egypt
by: Behiry, Iman K., et al.
Published: (2012)

Phenotypic and Genotypic Characterization of Enteropathogenic Escherichia coli (EPEC) strains in Tehran, Iran
by: Asadi Karam, MR, et al.
Published: (2010)

10.321/eid0805.Typical and Atypical Enteropathogenic Escherichia coli
by: Trabulsi, Luiz R., et al.
Published: (2002)

Ecto-5′-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli
by: Crane, John K., et al.
Published: (2007)

Atypical Enteropathogenic Escherichia coli Infection and Prolonged Diarrhea in Children
by: Nguyen, Rang N., et al.
Published: (2006)